J. Goldman & Co’s Bio-Techne TECH Stock Holding History

J. Goldman & Co’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-100,000	Closed	-$5.88M	–	877
2025 Q4	$5.88M	Buy	+100,000	New	+$6.08M	0.15%	171

Other funds holding TECH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

J. Goldman & Co's TECH Position: Q1 2026 in Review

J. Goldman & Co sold out of Bio-Techne (TECH) in Q1 2026, closing a stake of 22,500 shares — an estimated $1.32M sold.

J. Goldman & Co first reported a position in TECH in Q4 2025 and held it in 1 quarter. The position peaked at $1.32M in Q4 2025. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

J. Goldman & Co reported no remaining Bio-Techne position as of Q1 2026 after selling out during the quarter.
J. Goldman & Co sold 22,500 Bio-Techne shares in Q1 2026, an estimated $1.32M.
J. Goldman & Co first reported a position in Bio-Techne in Q4 2025 and held it in 1 quarter.
J. Goldman & Co's Bio-Techne position peaked at $1.32M in Q4 2025.
582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on J. Goldman & Co's 13F filing for Q1 2026, filed 15 May 2026.